Literature DB >> 32170360

Residual disease by flow cytometry in patients with nucleophosmin-mutated acute myeloblastic leukemia.

Marc Sorigue1, Andrea Espasa2, Lurdes Zamora2, Jordi Junca2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32170360     DOI： 10.1007/s00277-020-03997-5

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  4 in total

1.  The predictive value of minimal residual disease when facing the inconsistent results detected by real-time quantitative PCR and flow cytometry in NPM1-mutated acute myeloid leukemia.

Authors:  Meng-Ge Gao; Guo-Rui Ruan; Ying-Jun Chang; Yan-Rong Liu; Ya-Zhen Qin; Qian Jiang; Hao Jiang; Xiao-Jun Huang; Xiao-Su Zhao
Journal:  Ann Hematol       Date:  2019-11-25       Impact factor: 3.673

2.  The fickle P value generates irreproducible results.

Authors:  Lewis G Halsey; Douglas Curran-Everett; Sarah L Vowler; Gordon B Drummond
Journal:  Nat Methods       Date:  2015-03       Impact factor: 28.547

3.  CD34 expression and the outcome of nucleophosmin 1-mutated acute myeloid leukemia.

Authors:  Jordi Juncà; Olga Garcia; Montse Garcia-Caro; Jordi Vila; Lurdes Zamora; Marta Cabezón; Esther Alonso; Esmeralda de la Banda; Inés Rodríguez-Hernández; Josep Maria Ribera; Fuensanta Millá
Journal:  Ann Hematol       Date:  2016-09-05       Impact factor: 3.673

4.  CD34+CD38- leukemic stem cell frequency to predict outcome in acute myeloid leukemia.

Authors:  Tim Grob; Rosa Meijer; Diana Hanekamp; Peter J M Valk; Mojca Jongen-Lavrencic; Gert J Ossenkoppele; Gerrit J Schuurhuis; Wendelien Zeijlemaker; Angèle Kelder; Jannemieke C Carbaat-Ham; Yvonne J M Oussoren-Brockhoff; Alexander N Snel; Dennis Veldhuizen; Willemijn J Scholten; Johan Maertens; Dimitri A Breems; Thomas Pabst; Markus G Manz; Vincent H J van der Velden; Jennichjen Slomp; Frank Preijers; Jacqueline Cloos; Arjan A van de Loosdrecht; Bob Löwenberg
Journal:  Leukemia       Date:  2018-12-12       Impact factor: 11.528
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.